immunity News and Research

RSS

New universal flu vaccine protects mice against diverse variants of influenza A and B viruses

A new universal flu vaccine protects against diverse variants of both influenza A and B viruses in mice, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.

26 Aug 2022

Study identifies novel neutrophil biomarkers of delayed recovery in COVID-19

Researchers map the proteomes of peripheral blood neutrophils isolated from hospitalized COVID-19 patients using high-resolution LC-MS.

25 Aug 2022

A complex immunological landscape emerges in South Africa after Omicron BA.1/BA.2

Researchers evaluate infection rates and changes in the immunological history of COVID-19 patients over time.

25 Aug 2022

Investigating the links between the rate of new cases, mutations, and selection in SARS-CoV2 virus

How many times in the last 18 months have you seen a map that looks like the one above? It looks like a population density map, but in fact, it is a case total for the COVID19 rates from Johns Hopkins Coronavirus Research Center (collected on 24 May 2022).

25 Aug 2022

Study investigates factors that influence immune responses over 15 months after SARS-CoV-2 infection

In a new study, the long-term humoral immunity to SARS-CoV-2 was investigated.

25 Aug 2022

What is the association between T lymphocyte-mediated immune responses and COVID-19 severity?

Researchers examined the relationship between cell-mediated or T lymphocyte-mediated immunity and SARS-CoV-2 infection severity.

25 Aug 2022

Study suggests inclusion of the Omicron BA.5 strain in a SARS-CoV-2 vaccine would be beneficial in protection against this widely circulating variant

Researchers explored neutralizing antibodies against SARS-CoV-2 Omicron BA.1, BA.2, and BA.5 lineage infected patients.

25 Aug 2022

Study shows how Klebsiella pneumoniae suppresses the body's defenses

New research published in Cell Reports has shown how the bacterium Klebsiella pneumoniae suppresses our body's defences, resulting in it being unable to clear infection.

24 Aug 2022

Using the power of CRISPR to engineer better, stronger, longer-lived T cells

T cells used in immunotherapy treatments can get exhausted by the task of fighting cancer cells or get shutdown as they enter tumors.

24 Aug 2022

Experimental, genetically attenuated malaria vaccine warrants further exploration

Findings from a preliminary human study of an experimental, genetically attenuated malaria parasite immunization show this vaccine warrants further exploration.

24 Aug 2022

Researchers identify a potential new therapeutic approach to fight angioimmunoblastic T-cell lymphoma

A type of blood cell cancer called angioimmunoblastic T-cell lymphoma (AITL) can develop as mutations accumulate with age in the stem cells from which the T cells in the blood develop.

24 Aug 2022

The role of SARS-CoV-2-specific T cells induced by infection, vaccination, or their combination in disease protection

Researchers evaluated how SARS-CoV-2-specific-T lymphocytes induced by infection, vaccination, or both conferred protection against severe COVID-19.

24 Aug 2022

Absolute vaccine effectiveness for third and fourth doses of mRNA COVID-19 vaccine against Omicron

Researchers analyzed the efficacy of the SARS-CoV-2 fourth-dose vaccination relative to no vaccination towards the Omicron BA.1 variant.

24 Aug 2022

Updated guidelines on the Valneva SARS-CoV-2 vaccine

The WHO provides interim guidelines for the use of the Valneva vaccine.

23 Aug 2022

Unconventional T cells influence immune responses in the lymph nodes

Lymph nodes trigger very different immune responses – depending on which body tissue they are connected to. Special T cells are responsible for this newly discovered relation.

23 Aug 2022

Wyss Institute's DNA nanotechnology-driven SPEAR protein-detection technology licensed to Spear Bio

Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc.announced that the Institute's DNA nanotechnology-driven ultrasensitive SPEAR protein-detection technology has been licensed to the newly formed Boston-based startup.

23 Aug 2022

immunity News and Research

New universal flu vaccine protects mice against diverse variants of influenza A and B viruses

Study identifies novel neutrophil biomarkers of delayed recovery in COVID-19

A complex immunological landscape emerges in South Africa after Omicron BA.1/BA.2

Investigating the links between the rate of new cases, mutations, and selection in SARS-CoV2 virus

Study investigates factors that influence immune responses over 15 months after SARS-CoV-2 infection

What is the association between T lymphocyte-mediated immune responses and COVID-19 severity?

Study suggests inclusion of the Omicron BA.5 strain in a SARS-CoV-2 vaccine would be beneficial in protection against this widely circulating variant

Study shows how Klebsiella pneumoniae suppresses the body's defenses

Using the power of CRISPR to engineer better, stronger, longer-lived T cells

Experimental, genetically attenuated malaria vaccine warrants further exploration

Researchers identify a potential new therapeutic approach to fight angioimmunoblastic T-cell lymphoma

The role of SARS-CoV-2-specific T cells induced by infection, vaccination, or their combination in disease protection

Absolute vaccine effectiveness for third and fourth doses of mRNA COVID-19 vaccine against Omicron

Updated guidelines on the Valneva SARS-CoV-2 vaccine

Unconventional T cells influence immune responses in the lymph nodes

Wyss Institute's DNA nanotechnology-driven SPEAR protein-detection technology licensed to Spear Bio

RCSI research provides greater insight into the causes of Long COVID syndrome

DNA origami as an alternative platform to display the RBD of SARS-CoV-2

What risk factors are associated with post-acute sequelae of SARS-CoV-2?

Clinicopathological correlations and obstetric management of pregnant women with monkeypox virus infection

Industry Focus eBook - Cell biology (5th edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News